These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26006236)

  • 1. Vasa vasorum in atherosclerosis and clinical significance.
    Xu J; Lu X; Shi GP
    Int J Mol Sci; 2015 May; 16(5):11574-608. PubMed ID: 26006236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasa vasorum and atherosclerosis - Quid novi?
    Langheinrich AC; Kampschulte M; Buch T; Bohle RM
    Thromb Haemost; 2007 Jun; 97(6):873-9. PubMed ID: 17549287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model.
    Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z
    J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
    Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
    Front Immunol; 2018; 9():706. PubMed ID: 29719532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis.
    Gössl M; Versari D; Hildebrandt HA; Bajanowski T; Sangiorgi G; Erbel R; Ritman EL; Lerman LO; Lerman A
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 20129528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice.
    Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):347-52. PubMed ID: 16293797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of adventitial vasa vasorum and intraplaque neovascularization in carotid atherosclerotic lesions with contrast-enhanced ultrasound and their role in atherosclerosis.
    Partovi S; Loebe M; Noon GP; Davies MG; Karimi S; Zipp L; Feinstein SB; Staub D
    Methodist Debakey Cardiovasc J; 2011; 7(4):37-40. PubMed ID: 22143476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.
    Gössl M; Herrmann J; Tang H; Versari D; Galili O; Mannheim D; Rajkumar SV; Lerman LO; Lerman A
    Basic Res Cardiol; 2009 Nov; 104(6):695-706. PubMed ID: 19458984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
    Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y
    Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
    Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal characterization of the functional density of the vasa vasorum by contrast-enhanced ultrasonography maximum intensity projection imaging.
    Lee SC; Carr CL; Davidson BP; Ellegala D; Xie A; Ammi A; Belcik T; Lindner JR
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1265-72. PubMed ID: 21163455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasa Vasorum Restructuring in Human Atherosclerotic Plaque Vulnerability: A Clinical Optical Coherence Tomography Study.
    Taruya A; Tanaka A; Nishiguchi T; Matsuo Y; Ozaki Y; Kashiwagi M; Shiono Y; Orii M; Yamano T; Ino Y; Hirata K; Kubo T; Akasaka T
    J Am Coll Cardiol; 2015 Jun; 65(23):2469-77. PubMed ID: 26065984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting vasa vasorum dysfunction to prevent atherosclerosis.
    Boyle EC; Sedding DG; Haverich A
    Vascul Pharmacol; 2017 Sep; 96-98():5-10. PubMed ID: 28830735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication of inwardly projecting neovessels with the lumen contributes to symptomatic intraplaque hemorrhage in carotid artery stenosis.
    Horie N; Morofuji Y; Morikawa M; Tateishi Y; Izumo T; Hayashi K; Tsujino A; Nagata I
    J Neurosurg; 2015 Nov; 123(5):1125-32. PubMed ID: 26090834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events.
    Staub D; Patel MB; Tibrewala A; Ludden D; Johnson M; Espinosa P; Coll B; Jaeger KA; Feinstein SB
    Stroke; 2010 Jan; 41(1):41-7. PubMed ID: 19910551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Ultrasound Imaging Quantification of Adventitial Vasa Vasorum in a Rabbit Model of Varying Degrees of Atherosclerosis.
    Li X; Zhang R; Li Z; Ning C; Wang Z; Dang M; Peng Y; Han X; Sun L; Tian J
    Sci Rep; 2017 Aug; 7(1):7032. PubMed ID: 28765521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Coronary Intimal Plaques by Optical Coherence Tomography in Arteries With Versus Without Internal Running Vasa Vasorum.
    Amano H; Koizumi M; Okubo R; Yabe T; Watanabe I; Saito D; Toda M; Ikeda T
    Am J Cardiol; 2017 May; 119(10):1512-1517. PubMed ID: 28347486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2.
    Wihastuti TA; Amiruddin R; Cesa FY; Alkaf AI; Setiawan M; Heriansyah T
    J Basic Clin Physiol Pharmacol; 2020 Feb; 30(6):. PubMed ID: 32031980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia--implications for vulnerable plaque-development.
    Gössl M; Versari D; Mannheim D; Ritman EL; Lerman LO; Lerman A
    Atherosclerosis; 2007 Jun; 192(2):246-52. PubMed ID: 16919638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.